ARDT ardenthealth.com: Rasio rega marang prakiraan pendapatan
Despite staffing shortages and nursing turnover, Ardent Health Partners, Inc. (ARDT) is actively recruiting IT talent. This chart of the company's expected P/S ratio visualizes market expectations, where 0.30 shows the current value of the metric. The implementation of AI in patient logistics optimizes the network's operations, while competent management ensures expense transparency and high operational efficiency for the recent IPO.
Rincian metrik komprehensif lan analitis Ardent Health Corp (ARDT)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- indikator nilai buku ekuitas:
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Ardent Health Partners, Inc.|ARDT - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Ardent Health Partners, Inc.|ARDT - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Ardent Health Corp|ARDT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Ardent Health Partners|Indikator likuiditas cepet ardenthealth.com
- indikator pendapatan resik lan kelipatan nilai:
ARDT - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep Ardent Health Partners, Inc.|ARDT - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Ardent Health Partners Inc|ARDT - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Ardent Health Corp|ARDT - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi resik saben saham (EPS TTM) Ardent Health Partners|ARDT - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ardenthealth.com|ARDT - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Ardent Health Partners, Inc.
- rincian pendapatan lan dodolan emiten:
Analisis wiwitan perusahaan:Ardent Health Partners ARDT
The forward P/S reflects the ratio of the company's market capitalization to projected revenue, allowing for an assessment of the value of each unit of expected sales. For Ardent Health Partners, Inc. (ARDT), this indicator demonstrates the scaling efficiency of hospital networks in major metropolitan areas. Analyzing the business's forward P/S helps identify asset overvaluation relative to the expansion rates of medical systems. The stability of this metric confirms the resilience of the investment profile when implementing unified management standards.
Pesaing Ardent Health Partners, Inc.
Multiplikator Forward P/S HCA (HCA Healthcare)|Tenet Healthcare Corp (THC) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|FMS - Rasio rega marang prakiraan pendapatan|SOLV (Solventum Health) - Kapitalisasi marang prakiraan pendapatan|EHC (Encompass Health) - Multiplikator forward rega marang pendapatan|UHS: Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan DVA|RDNT: Rega forward marang dodolan|Multiplikator Forward P/S OPCH|SGRY (Surgery Partners Group) - Rega forward marang dodolan|Multiplikator Forward P/S PINC (Premier, Inc.)|nationalvision.com (EYE) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Progyny - Multiplikator Forward P/S|SEM - Multiplikator Forward P/S|Apollo Medical Holdings (ASTH) - Rasio rega marang prakiraan pendapatan|MD (MEDNAX) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan USPH|PNTG (pennantgroup.com) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S ORGO|NUTX (Nutex Health Inc) - Rega forward marang dodolan|Auna Health - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan SBC|EOLS - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CYH|SKIN: Multiplikator Forward P/S|MediWound (MDWD) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Biote Corp|JYNT: Rega forward marang dodolan|Multiplikator forward rega marang pendapatan DCGO (DocGo Inc.)|Rasio rega marang pendapatan sing dikarepake PIII|Rasio rega marang prakiraan pendapatan Gain Therapeutics GANX|EUDA: Kapitalisasi marang prakiraan pendapatan|Basel Medical Group Limited - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep CollPlant Biotechnologies|Cuprina Holdings (Cayman) Ltd (CUPR) - Rasio rega marang prakiraan pendapatan|concordmedical.com - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan American Shared Hospital Services|MEDIROM Healthcare Group Inc. (MRM) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan ALBT (Avalon GloboCare)|DHAI (DIH Group) - Rega forward marang dodolan|Multiplikator Forward P/S XAGE (Longevity Health Holdings)|Rasio kapitalisasi marang dodolan sing dikarepake newgenivf.com (NIVF)|ATIP - Rasio rega marang prakiraan pendapatan|CMAX (CareMax Inc.) - Kapitalisasi marang prakiraan pendapatan|KDLY: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan ModivCare Corp|Multiplikator forward rega marang pendapatan NVOS|SunLink Health Systems, Inc (SSY) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S BACK
